Advertisement
Life-Sciences-Europe.com
The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Theolytics Closes £19m Financing Round (2024-04-17)
> Sound Bioventures joins strong international syndicate comprising M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises and The University of Oxford. > New funding enables Theolytics to advance lead candidate THEO-260 through to clinical pro... - Domain Therapeutics Appoints Sean A. MacDonald as CEO (2024-04-17)
> Sean will drive the Company through its next phase of growth and bring its highly promising pipeline through clinical development > He brings more than 20 years of senior executive experience in the life science industry across business development, operations... - Bruker to Acquire NanoString Assets for $392.6m in Cash (2024-04-17)
> Bruker Wins Competitive Auction > Acquisition Ensures Continued Customer Access to NanoString’s Products > Transaction Expected to Close in early-May 2024 NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of li... - Medincell & AbbVie: up to $1.9b for Long-acting Injectables (2024-04-16)
> Medincell will receive an upfront payment of $35 million and is eligible for up to $1.9 billion in potential development and commercial milestones, plus royalties on worldwide sales. > Medincell and AbbVie will co-develop, and AbbVie will commercialize up to s... - Naobios and Sumagen Partner to Develop HIV Vaccine (2024-04-15)
Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of viru... - FundaMental Appoints Dirk Beher as CEO & Adds Investor NVF (2024-04-11)
> Highly experienced biotech executive, with over a quarter of a century of CNS drug discovery experience > Dr. Beher takes over the role of Chief Executive Officer from co-founder Dr. Thomas Schulze > FundaMental Pharma recently raised additional seed fundin... - Axolabs & Asahi Kasei to Build Oligo Facility in Berlin (2024-04-11)
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facilit... - CRS Appoints Catherine Canales as Chief Commercial Officer (2024-04-10)
CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), announced the appointment of Catherine Canales as Chief Commercial Officer (CCO), effective today, completing the new CRS leadership team. Together, they are committed to st... - Boehringer Ingelheim BioChina Able to Supply EU & US Markets (2024-04-09)
Boehringer Ingelheim Biopharmaceuticals China (BioChina), in collaboration with a customer, has successfully passed pre-approval inspections by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). As a result, the customer is now... - Seaport Therapeutics Launches with $100m Series A Financing (2024-04-09)
> Daphne Zohar, Founding CEO of PureTech Health and Co-Founder of Karuna Therapeutics, is Founder, Chief Executive Officer and Member of the Board of Directors of Seaport > Steven M. Paul, M.D., former CEO and Chair of Karuna Therapeutics, President of Lilly Res...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!
» Start here with the latest News!Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top